Qpex Biopharma
Acquired
Innovating Treatments To Address the Global Public Health Burden of Infectious Diseases.
- Headquarters
- San Diego, California
- Founded
- 2018
- Business Model
- B2B
- Website
- qpexbio.com
- Total Funding
- $33.0M
- Last Round
- $33.0M Series AOct 2018
About
Qpex Biopharma, now a Shionogi Group Company, is a resistance-focused infectious disease company developing a pipeline of novel antibiotics and anti-infectives targeting drug-resistant bacterial pathogens. The company focuses on developing clinically proven treatments for critically resistant gram-negative organisms, addressing the global public health crisis of antimicrobial resistance. Qpex has partnered with BARDA to advance its antibiotic portfolio.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account